Stifel Financial Corp Sarepta Therapeutics, Inc. Transaction History
Stifel Financial Corp
- $93.7 Billion
- Q4 2024
A detailed history of Stifel Financial Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 10,069 shares of SRPT stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,069
Previous 37,207
72.94%
Holding current value
$1.01 Million
Previous $4.65 Million
73.66%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding SRPT
# of Institutions
536Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.04 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$915 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$876 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$436 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$410 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $8.82B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...